Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications

SAN DIEGO , March 16, 2022 -- Illumina, Inc. (NASDAQ: ILMN) has invested in seven new genomics companies to join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge, UK.

Related Keywords

Georgia ,United States ,India ,Massachusetts Institute Of Technology ,Massachusetts ,United Kingdom ,Atlanta ,China ,Boston ,Virginia ,Cambridge ,Cambridgeshire ,Alex Aravanis ,Ben Johnson ,Amanda Cashin ,Cache Dna Inc ,Bio Private ,Nasdaq ,Purpose Health Inc ,Therapeutics Inc ,Sr Biosciences Inc ,Illumina Inc ,University Of Chicago ,Nonexomics Inc ,Illumina Accelerator ,Illumina Accelerator San Francisco Bay Area ,Global Head ,Illumina For ,San Francisco Bay ,Bay Area ,Managing Director ,National Head ,Early Stage Life Science ,Silicon Valley ,Global Funding ,Massachusetts Institute ,San Francisco Bay Area ,Greater Boston ,Northern Virginia ,Bio Private Limited ,Chief Technology Officer ,